ACE2 and renal carcinoma: Further, we specifically analyzed ACE2, which is a primary SARS-CoV receptor and DPP4, highly correlated to ACE2 across the kidney cancer subtypes along with immune cell signatures (innate and adaptive immunity, inflammatory cytokines, and chemokines) in 889 renal cancer samples and 409 normal kidney tissues.